WallStreetZenWallStreetZen

NASDAQ: CTHR
Charles & Colvard Ltd Stock

$1.61+0.01 (+0.63%)
Updated Jun 21, 2024
CTHR Price
$1.61
Fair Value Price
$0.17
Market Cap
$4.89M
52 Week Low
$1.53
52 Week High
$9.69
P/E
-0.27x
P/B
0.16x
P/S
0.44x
PEG
N/A
Dividend Yield
N/A
Revenue
$23.68M
Earnings
-$18.29M
Gross Margin
4.2%
Operating Margin
-76.98%
Profit Margin
-77.2%
Debt to Equity
0.33
Operating Cash Flow
-$6M
Beta
0.54
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CTHR Overview

Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. The company manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name. It also markets and distributes lab grown diamonds, and finished jewelry with lab grown diamonds under the Caydia brand. The company sells its products at wholesale prices to distributors, manufacturers, retailers, and designers; and to end-consumers at retail prices through charlesandcolvard.com, third-party online marketplaces, drop-ship, and other e-commerce outlets. Charles & Colvard, Ltd. was founded in 1995 and is headquartered in Morrisville, North Carolina.

Zen Score

Industry Average (24)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CTHR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CTHR ($1.61) is overvalued by 847.96% relative to our estimate of its Fair Value price of $0.17 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CTHR ($1.61) is not significantly undervalued (847.96%) relative to our estimate of its Fair Value price of $0.17 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CTHR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CTHR due diligence checks available for Premium users.

Be the first to know about important CTHR news, forecast changes, insider trades & much more!

CTHR News

Valuation

CTHR fair value

Fair Value of CTHR stock based on Discounted Cash Flow (DCF)
Price
$1.61
Fair Value
$0.17
Overvalued by
847.96%
CTHR ($1.61) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CTHR ($1.61) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CTHR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CTHR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.27x
Industry
4.11x
Market
30.75x

CTHR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.16x
Industry
2.54x
CTHR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CTHR's financial health

Profit margin

Revenue
$5.3M
Net Income
-$3.6M
Profit Margin
-69%
CTHR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CTHR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$41.0M
Liabilities
$10.0M
Debt to equity
0.33
CTHR's short-term assets ($21.29M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CTHR's short-term assets ($21.29M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CTHR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CTHR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.1M
Investing
-$235.6k
Financing
$500.0k
CTHR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CTHR vs Luxury Stocks

TickerMarket Cap1d %P/EP/B
CTHR$4.89M+0.69%-0.27x0.16x
JEWL$7.17M-2.66%-0.22x1.88x
BGI$46.08M-2.77%-6.65x-22.69x
FOSL$78.34M+3.50%-0.56x0.34x
ELA$124.55M+3.49%19.75x2.53x

Charles & Colvard Stock FAQ

What is Charles & Colvard's quote symbol?

(NASDAQ: CTHR) Charles & Colvard trades on the NASDAQ under the ticker symbol CTHR. Charles & Colvard stock quotes can also be displayed as NASDAQ: CTHR.

If you're new to stock investing, here's how to buy Charles & Colvard stock.

What is the 52 week high and low for Charles & Colvard (NASDAQ: CTHR)?

(NASDAQ: CTHR) Charles & Colvard's 52-week high was $9.69, and its 52-week low was $1.53. It is currently -83.38% from its 52-week high and 5.23% from its 52-week low.

How much is Charles & Colvard stock worth today?

(NASDAQ: CTHR) Charles & Colvard currently has 3,034,496 outstanding shares. With Charles & Colvard stock trading at $1.61 per share, the total value of Charles & Colvard stock (market capitalization) is $4.89M.

Charles & Colvard stock was originally listed at a price of $92.48 in Dec 31, 1997. If you had invested in Charles & Colvard stock at $92.48, your return over the last 26 years would have been -98.26%, for an annualized return of -14.43% (not including any dividends or dividend reinvestments).

How much is Charles & Colvard's stock price per share?

(NASDAQ: CTHR) Charles & Colvard stock price per share is $1.61 today (as of Jun 21, 2024).

What is Charles & Colvard's Market Cap?

(NASDAQ: CTHR) Charles & Colvard's market cap is $4.89M, as of Jun 24, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Charles & Colvard's market cap is calculated by multiplying CTHR's current stock price of $1.61 by CTHR's total outstanding shares of 3,034,496.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.